Reshma Rangwala

Insider Reports History

Entity
Individual
Location
River Oaks Tower, 3730 Kirby Drive, Suite 1200, Houston, TX
Signature
/s/Nancy Smith as Attorney-in-Fact for Reshma Rangwala
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Reshma Rangwala:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Karyopharm Therapeutics Inc. EVP & Chief Medical Officer Common 350K $420K $1.20 Mar 1, 2024 Direct
Karyopharm Therapeutics Inc. EVP & Chief Medical Officer Common Stock 343K $401K $1.17 Apr 22, 2024 Direct
Aravive, Inc. Chief Medical Officer Stock Option (Right to buy) 175K Jan 24, 2022 Direct

Insider Reports Filed by Reshma Rangwala

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KPTI Karyopharm Therapeutics Inc. Apr 22, 2024 1 -$7.94K 4 Apr 23, 2024 EVP & Chief Medical Officer
KPTI Karyopharm Therapeutics Inc. Feb 29, 2024 2 -$25.5K 4 Mar 4, 2024 EVP & Chief Medical Officer
KPTI Karyopharm Therapeutics Inc. Feb 28, 2024 1 $0 4 Feb 29, 2024 EVP & Chief Medical Officer
KPTI Karyopharm Therapeutics Inc. Jan 24, 2024 1 $0 4 Jan 25, 2024 EVP & Chief Medical Officer
KPTI Karyopharm Therapeutics Inc. Apr 20, 2023 2 -$27.4K 4 Apr 24, 2023 EVP & Chief Medical Officer
KPTI Karyopharm Therapeutics Inc. Feb 28, 2023 1 $0 4 Mar 2, 2023 EVP & Chief Medical Officer
KPTI Karyopharm Therapeutics Inc. Apr 29, 2022 2 $0 4 May 2, 2022 EVP & Chief Medical Officer
KPTI Karyopharm Therapeutics Inc. Apr 19, 2022 0 $0 3 Apr 29, 2022 EVP & Chief Medical Officer
ARAV Aravive, Inc. Jan 24, 2022 1 $0 4 Jan 25, 2022 Chief Medical Officer